Intervenant

Jan VIJG

Albert Einstein College of Medicine, New York

Jan Vijg, Ph.D., is Professor and Chairman of the Department of Genetics at the Albert Einstein College of Medicine in New York since 2008. He received his Ph.D. at the University of Leiden, The Netherlands, in 1987, and was previously an Associate Professor of Medicine at Harvard Medical School in Boston (1993-1999), a Professor of Physiology at the University of Texas Health Science Center in San Antonio, Texas (1999-2005), and a Professor at the Buck Institute for Research on Aging, Novato, California (2006-2008).With his research team he was the first to develop transgenic mouse models for studying mutagenesis in vivo (in 1989) and used these models ever since in studying the possible relationship between damage to the genome and aging. He has published more than 300 scientific articles, is inventor or co-inventor on 8 patents and co-founded two biotechnology companies. He is currently developing novel approaches in genomic medicine, with a focus on cancer and aging.

Publications:

Vijg J. Aging of the Genome. Oxford University Press, 2007, New York.

Vijg J., Campisi J. Puzzles, promises and a cure for ageing. Nature. 2008;454:1065-1071. PMC2774752

Vijg J. The American Technological Challenge: Stagnation and Decline in the 21st Century. Algora, 2011, New York.

Vijg J. Aging genomes: A necessary evil in the logic of life. Bioessays 2014 [Epub ahead of print]

Vijg J., de Grey AD. Innovating Aging: Promises and Pitfalls on the Road to Life Extension. Gerontology. 2014 Apr 9. [Epub ahead of print]